Veriheal
OCTOBER 5, 2020
The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .
Veriheal
MARCH 1, 2021
Severe and chronic pain. Seizures, including those characteristic of epilepsy. Previously, Nevada had legalized medical marijuana in 2000, and Nevada had reciprocity with all states. . Hepatitis C. Amyotrophic lateral Sclerosis. Crohn’s disease. Agitation of Alzheimer’s disease. Cachexia or wasting syndrome.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 20, 2019
sat on the Denver County Court bench 2000-2015. For example, there is a growing body of evidence that marijuana is working for chronic pain. Whether or not the pharmaceutical industry can produce a substance they can call a drug that would be approved for a pain indication remains the question,” [xiv]. Author Biography.
Cannabis Law Report
NOVEMBER 24, 2021
Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Refractory paediatric epilepsy. Cancer pain.
Sensi Seeds
DECEMBER 10, 2018
The study in question, published on October 8 2018 in the Population Health Management journal, is entitled Trends in Publications on Medical Cannabis from the Year 2000. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.
Expert insights. Personalized for you.
52 
Let's personalize your content